Henry Schein IncHSIC

Henry Schein’s latest quarterly filing reads less like a growth story and more like an oral exam nobody studied for. The company, which markets itself as a one-stop shop for dentists, doctors, and anyone who needs to order latex gloves in bulk, reported $3.37 billion in revenue for the three months to 28 March, yet eked out net income of just $107 million. The operating cash flow number is the real kicker: negative $97 million, a figure that sounds less like a thriving ecosystem and more like a patient who forgot to pay the bill. Analysts expecting a margin expansion miracle will be left holding the drill. (source: 10-Q, period ending 2026-03-28, https://www.sec.gov/Archives/edgar/data/1000228/000100022826000032/hsic-20251231.htm)

What Henry Schein actually does is simple: it’s a massive distributor of medical and dental supplies, equipment, and services, from gloves and drills to billing software and practice consulting. The company’s glossy “SolutionsHub” promises best-in-class clinical and operational tools for healthcare providers, while its “Practice Services” division sells consulting, training, and revenue-cycle management. The marketing speaks of innovation and equity, but the balance sheet whispers about leverage and liquidity. The gap between the polished platform story and the filed numbers is wide enough to slip a molar through. (source: Practice Services rail, https://www.henryschein.com/us-en/dental/business-solutions/about-business-solutions.aspx?cdivid=dental; Solutions & Services rail, https://www.henryschein.com/us-en/medical/solutions-services/about-solutions-services.aspx?cdivid=medical)

The filings, however, are unambiguous. Revenue clocked in at $3.37 billion, up from the same quarter last year, but net income was only $107 million, giving a net margin of 3.2%. Operating income stood at $182 million, while the company’s diluted EPS was $0.92 on 116.1 million shares. Assets totalled $11.3 billion against liabilities of $6.48 billion, leaving equity at $3.27 billion. The cash flow line is the stumper: operating cash flow was negative $97 million, while inventories sat at $2.01 billion, down $8 million from the prior quarter. The company’s Form SD, filed in May, talks up “ethical” supply chains and global health equity, but the 10-Q tells a different story: liabilities exceed equity by $3.21 billion, and the firm is haemorrhaging operating cash. (source: 10-Q (2026-03-28), https://www.sec.gov/Archives/edgar/data/1000228/000100022826000032/hsic-20251231.htm; HSIC SD (2026-05-29), https://www.sec.gov/Archives/edgar/data/1000228/000100022826000027/formsdfiling.htm)

The company’s own product pages-“Henry Schein SolutionsHub” and “Practice Services”-promise clinical excellence, financial tools, and operational support, yet the filings show the firm is more reliant on a $2.01 billion inventory pile than on any margin miracle. The SolutionsHub page features best-in-class clinical and operational solutions, while the Practice Services page hawks consulting, training, and billing support. The visuals are slick, the language polished, but the cash flow statement is the patient’s chart after a root canal. (source: Henry Schein SolutionsHub rail, https://www.henryschein.com/us-en/medical/solutions-services/about-solutions-services.aspx?cdivid=medical; Practice Services rail, https://www.henryschein.com/us-en/dental/business-solutions/about-business-solutions.aspx?cdivid=dental)

For anyone trying to chart the company’s recent moves, the SEC filings are the only map that matters. The company’s 144 insider sales in June-two separate filings-highlight a liquidity event that would make any small-cap investor’s stomach churn, especially when the diluted EPS is only $0.92. The balance sheet shows equity of $3.27 billion against liabilities of $6.48 billion, a leverage ratio that would raise eyebrows in any dental practice, let alone a Fortune 500 healthcare distributor. The cash flow line, meanwhile, remains stubbornly negative, leaving investors to wonder whether the company’s “solutions” are more about selling than about earning. (source: 144 (2026-06-30), https://www.sec.gov/Archives/edgar/data/1000228/0001959173260004962/xsl144X01/primary_doc.xml; 10-Q (2026-03-28), https://www.sec.gov/Archives/edgar/data/1000228/000100022826000032/hsic-20251231.htm)

The company’s Form SD, filed in May, promises “advancing policies, solutions, and innovation,” but the 10-Q shows the firm’s liabilities exceed its equity by $3.21 billion. The gap between the marketing and the mechanics is wide enough to drive a truck through, and the cash flow line is the patient who forgot to pay the bill. If Henry Schein wants to live up to its own hype, it might start by generating some cash instead of selling it. (source: HSIC SD (2026-05-29), https://www.sec.gov/Archives/edgar/data/1000228/000100022826000027/formsdfiling.htm; 10-Q (2026-03-28), https://www.sec.gov/Archives/edgar/data/1000228/000100022826000032/hsic-20251231.htm)